Michael Aronstein - Dec 31, 2021 Form 5 Insider Report for AngioGenex, Inc. (AGGX)

Role
Director, CHAIRMAN, 10%+ Owner
Signature
/s/ MICHAEL ARONSTEIN
Stock symbol
AGGX
Transactions as of
Dec 31, 2021
Transactions value $
$134,362,775,000
Form type
5
Date filed
2/15/2022, 03:41 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGGX Common Stock Award $6.25B +250K +4.35% $25,000.00* 6M Oct 23, 2019 Direct
transaction AGGX Common Stock Award $6.25B +250K +4.35% $25,000.00* 6M Dec 30, 2019 Direct
transaction AGGX Common Stock Award $125M +25K +0.41% $5,000.00* 6.13M Mar 3, 2020 Direct
transaction AGGX Common Stock Award $500M +50K +0.82% $10,000.00* 6.13M Aug 5, 2020 Direct
transaction AGGX Common Stock Award $556M +55.6K +0.91% $10,000.00* 6.13M Oct 8, 2020 Direct
transaction AGGX Common Stock Award $40B +400K +5.63% $100,000.00* 7.51M Mar 2, 2021 Direct
transaction AGGX Common Stock Award $5.68B +227K +3.12% $25,000.00* 7.51M Jun 8, 2021 Direct
transaction AGGX Common Stock Award $75B +750K +11.1% $100,000.00* 7.51M Aug 31, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGGX Stock Option Award $105K +3M $0.04* 3M Jan 15, 2019 Common Stock 3M $0.35 Direct
transaction AGGX Stock Option Award $260K +2M +66.67% $0.13* 5M Sep 2, 2021 Common Stock 2M $0.13 Direct
transaction AGGX Convertible Note Award $60K +240K +4.8% $0.25* 5.24M Nov 2, 2021 Common Stock 240K $25.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.